MC4R and type 2 diabetes mellitus: A recent genomic association study conducted within the European population revealed 61 non-synonymous variants in MC4R, of which 77% produce a decreased level of MC4R that is insufficient to bind to β-arrestin-2 and increases BMI and risks of obesity and T2DM [47].